Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml
Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml is a medicine authorised by Swissmedic under authorisation number 65510. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 July 2016 and the authorisation is valid without a time limit. ATC code L04AX03 places the medicine in the group Immunosuppressants.
| Authorisation number | 65510 |
|---|---|
| Name | Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml |
| Full name | Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AX03 |
| First authorisation | 20 July 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
| 3 | Methotrexat-Mepha rheuma/derm 10 mg/0.4 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
| 4 | Methotrexat-Mepha rheuma/derm 12.5 mg/0.3125 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
| 5 | Methotrexat-Mepha rheuma/derm 15 mg/0.375 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
| 6 | Methotrexat-Mepha rheuma/derm 17.5 mg/0.4375 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
| 7 | Methotrexat-Mepha rheuma/derm 20 mg/0.5 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
| 8 | Methotrexat-Mepha rheuma/derm 25 mg/0.625 ml, Injektionslösung in einer Fertigspritze | A | 20 July 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Stück | L04AX03 | 07.10.6. | A |
| 3 | 1 | Stück | L04AX03 | 07.10.6. | A |
| 4 | 1 | Stück | L04AX03 | 07.10.6. | A |
| 5 | 1 | Stück | L04AX03 | 07.10.6. | A |
| 6 | 1 | Stück | L04AX03 | 07.10.6. | A |
| 7 | 1 | Stück | L04AX03 | 07.10.6. | A |
| 8 | 1 | Stück | L04AX03 | 07.10.6. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml authorised in Switzerland?
Yes. Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml is authorised by Swissmedic under authorisation number 65510, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml have?
Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Methotrexat-Mepha rheuma/derm 7.5 mg/0.30 ml?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.